Literature DB >> 20588169

A TRIM5alpha exon 2 polymorphism is associated with protection from HIV-1 infection in the Pumwani sex worker cohort.

Heather Price1, Philip Lacap, Jeff Tuff, Charles Wachihi, Joshua Kimani, Terry B Ball, Ma Luo, Francis A Plummer.   

Abstract

OBJECTIVE: The innate immune component TRIM5alpha has the ability to restrict retrovirus infection in a species-specific manner. TRIM5alpha of some primate species restricts infection by HIV-1, whereas human TRIM5alpha lacks this specificity. Previous studies have suggested that certain polymorphisms in human TRIM5alpha may enhance or impair the proteins affinity for HIV-1. This study investigates the role of TRIM5alpha polymorphisms in resistance/susceptibility to HIV-1 within the Pumwani sex worker cohort in Nairobi, Kenya. A group of women within this cohort remain HIV-1-seronegative and PCR-negative despite repeated exposure to HIV-1 through active sex work.
DESIGN: A 1 kb fragment of the TRIM5alpha gene, including exon 2, from 1032 women enrolled in the Pumwani sex worker cohort was amplified and sequenced. Single-nucleotide polymorphisms (SNPs) and haplotypes were compared between HIV-1-positive and resistant women.
METHODS: The TRIM5alpha exon 2 genomic fragment was amplified, sequenced and genotyped. Pypop32-0.6.0 was used to determine SNP and haplotype frequencies and statistical analysis was carried out using SPSS-13.0 for Windows.
RESULTS: A TRIM5alpha SNP (rs10838525) resulting in the amino acid change from arginine to glutamine at codon 136, was enriched in HIV-1-resistant individuals [P = 1.104E-05; odds ratio (OR) 2.991; 95% confidence interval (CI) 1.806-4.953] and women with 136Q were less likely to seroconvert (P = 0.002; log-rank 12.799). Wild-type TRIM5alpha exon 2 was associated with susceptibility to HIV-1 (P = 0.006; OR 0.279; 95% CI 0.105-0.740) and rapid seroconversion (P = 0.001; log-rank 14.475).
CONCLUSIONS: Our findings suggest that a shift from arginine to glutamine at codon 136 in the coiled-coil region of TRIM5alpha confers protection against HIV-1 in the Pumwani sex worker cohort.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20588169      PMCID: PMC2921035          DOI: 10.1097/QAD.0b013e32833b5256

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  25 in total

1.  [Weights in Horvitz-Thompson statistic for complex samples].

Authors:  H Xue; G Yang
Journal:  Wei Sheng Yan Jiu       Date:  2000-01-30

2.  In defense of the cell: TRIM5alpha interception of mammalian retroviruses.

Authors:  Kyeongeun Lee; Vineet N KewalRamani
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-13       Impact factor: 11.205

Review 3.  Intrinsic immunity: a front-line defense against viral attack.

Authors:  Paul D Bieniasz
Journal:  Nat Immunol       Date:  2004-11       Impact factor: 25.606

4.  The TRIM5alpha B-box 2 domain promotes cooperative binding to the retroviral capsid by mediating higher-order self-association.

Authors:  Xing Li; Joseph Sodroski
Journal:  J Virol       Date:  2008-09-17       Impact factor: 5.103

5.  Human tripartite motif 5alpha domains responsible for retrovirus restriction activity and specificity.

Authors:  David Perez-Caballero; Theodora Hatziioannou; Annie Yang; Simone Cowan; Paul D Bieniasz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates.

Authors:  Byeongwoon Song; Bert Gold; Colm O'Huigin; Hassan Javanbakht; Xing Li; Matthew Stremlau; Cheryl Winkler; Michael Dean; Joseph Sodroski
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

7.  Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya.

Authors:  K R Fowke; N J Nagelkerke; J Kimani; J N Simonsen; A O Anzala; J J Bwayo; K S MacDonald; E N Ngugi; F A Plummer
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

8.  Trim5alpha protein restricts both HIV-1 and murine leukemia virus.

Authors:  Melvyn W Yap; Sébastien Nisole; Clare Lynch; Jonathan P Stoye
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

9.  TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.

Authors:  Michel J Perron; Matthew Stremlau; Byeongwoon Song; Wes Ulm; Richard C Mulligan; Joseph Sodroski
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-27       Impact factor: 11.205

10.  A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.

Authors:  Melvyn W Yap; Sébastien Nisole; Jonathan P Stoye
Journal:  Curr Biol       Date:  2005-01-11       Impact factor: 10.834

View more
  22 in total

Review 1.  The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors.

Authors:  Richard A Koup; Barney S Graham; Daniel C Douek
Journal:  Nat Rev Immunol       Date:  2010-12-17       Impact factor: 53.106

Review 2.  Control of HIV infection by IFN-α: implications for latency and a cure.

Authors:  Nollaig M Bourke; Silvia Napoletano; Ciaran Bannan; Suaad Ahmed; Colm Bergin; Áine McKnight; Nigel J Stevenson
Journal:  Cell Mol Life Sci       Date:  2017-10-07       Impact factor: 9.261

Review 3.  TRIM5 structure, HIV-1 capsid recognition, and innate immune signaling.

Authors:  Markus G Grütter; Jeremy Luban
Journal:  Curr Opin Virol       Date:  2012-03-05       Impact factor: 7.090

4.  A naturally occurring single amino acid substitution in human TRIM5α linker region affects its anti-HIV type 1 activity and susceptibility to HIV type 1 infection.

Authors:  Emi E Nakayama; Toshiaki Nakajima; Gurvinder Kaur; Jun-ich Mimaya; Hiroshi Terunuma; Narinder Mehra; Akinori Kimura; Tatsuo Shioda
Journal:  AIDS Res Hum Retroviruses       Date:  2013-02-26       Impact factor: 2.205

5.  Pressure from TRIM5α contributes to control of HIV-1 replication by individuals expressing protective HLA-B alleles.

Authors:  Clémence Granier; Emilie Battivelli; Camille Lécuroux; Alain Venet; Olivier Lambotte; Marion Schmitt-Boulanger; Constance Delaugerre; Jean-Michel Molina; Lisa A Chakrabarti; François Clavel; Allan J Hance
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

6.  A genetic polymorphism of FREM1 is associated with resistance against HIV infection in the Pumwani sex worker cohort.

Authors:  Ma Luo; James Sainsbury; Jeffrey Tuff; Philip A Lacap; Xin-Yong Yuan; Taha Hirbod; Joshua Kimani; Charles Wachihi; Sue Ramdahin; Thomas Bielawny; Joanne Embree; Kristina Broliden; T Blake Ball; Francis A Plummer
Journal:  J Virol       Date:  2012-08-22       Impact factor: 5.103

7.  Stabilized human TRIM5α protects human T cells from HIV-1 infection.

Authors:  Max W Richardson; Lili Guo; Frances Xin; Xiaolu Yang; James L Riley
Journal:  Mol Ther       Date:  2014-03-25       Impact factor: 11.454

8.  TRIM5 gene polymorphisms in HIV-1-infected patients and healthy controls from Northeastern Brazil.

Authors:  Ronaldo Celerino da Silva; Antonio Victor Campos Coelho; Luiz Cláudio Arraes; Lucas André Cavalcanti Brandão; Sergio Crovella; Rafael Lima Guimarães
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

Review 9.  Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.

Authors:  Jesper Melchjorsen
Journal:  Viruses       Date:  2013-01-31       Impact factor: 5.048

10.  Role of Human TRIM5α in Intrinsic Immunity.

Authors:  Emi E Nakayama; Tatsuo Shioda
Journal:  Front Microbiol       Date:  2012-03-15       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.